|
1
|
How to screen non-viral gene delivery systems in vitro?
|
J Control Release
|
2011
|
1.17
|
|
2
|
Oxidative stress in obstructive nephropathy.
|
Int J Exp Pathol
|
2010
|
1.10
|
|
3
|
c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation.
|
J Pharmacol Exp Ther
|
2009
|
0.99
|
|
4
|
DNA nuclear targeting sequences for non-viral gene delivery.
|
Pharm Res
|
2011
|
0.80
|
|
5
|
Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection.
|
Eur J Pharmacol
|
2012
|
0.78
|
|
6
|
Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies.
|
Eur J Pharm Sci
|
2011
|
0.77
|
|
7
|
Inhibition of Octreotide Acylation Inside PLGA Microspheres by Derivatization of the Amines of the Peptide with a Self-Immolative Protecting Group.
|
Bioconjug Chem
|
2016
|
0.75
|
|
8
|
A nonviral carrier for targeted gene delivery to tumor cells.
|
Cancer Gene Ther
|
2004
|
0.75
|
|
9
|
Kinase inhibitor conjugates.
|
Curr Pharm Des
|
2012
|
0.75
|
|
10
|
Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.
|
Pharm Res
|
2014
|
0.75
|
|
11
|
Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
|
J Renin Angiotensin Aldosterone Syst
|
2004
|
0.75
|